US 11945830
Antiviral heterocyclic compounds
granted A61KA61K31/4355A61K31/4365
Quick answer
US patent 11945830 (Antiviral heterocyclic compounds) held by Enanta Pharmaceuticals, Inc. expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/4355, A61K31/4365, A61K31/437, A61K31/444